Subtypes of betaglycan and of type I and type II transforming growth factor‐β (TGF‐β) receptors with different affinities for TGF‐β1 and TGF‐β2 are exhibited by human placental trophoblast cells
- 1 February 1992
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 150 (2) , 334-343
- https://doi.org/10.1002/jcp.1041500217
Abstract
Transforming growth factor-β is likely to be an important factor controlling placental activities, including growth, differentiation, invasiveness, hormone production, and immunosuppression. We have used a chemical cross-linking technique with either 125I-TGF-β1 or 125I-TGF-β2 and bis(sulfosuccinimidyl) suberate (BS3) to characterize TGF-β binding components on human placental cells in primary culture. Trophoblast-enriched primary cultures exhibited a predominant affinity-labelled complex characteristic of membrane-anchored betaglycan (formerly termed the Type III TGF-β receptor) and relatively low levels of the Type I and Type II TGF-β receptor complexes. The results from affinity labelling saturation and competition experiments with TGF-β1 and TGF-β2 suggest the existence of two distinct subtypes of betaglycan: one subtype has a lower capacity and higher affinity, binds both TGF-β1 and TGF-β2, yet has a preferential affinity for TGF-β2; the second subtype has a higher capacity and lower affinity and binds TGF-β1 exclusively. In contrast, mesenchymal cell-enriched placental primary cultures possessed only one subtype of the betaglycan component that binds the two TGF-β isoforms with similar affinities and capacities as observed on most cell lines. These experiments demonstrate that the betaglycan component which exhibits a higher affinity for TGF-β2 than for TGF-β1, that we had observed previously on term placental membranes, is actually present on trophoblast cells. In addition to the two distinctive betaglycan subtypes, subtypes of the Type I and II TGF-β receptors were detected on the trophoblast-enriched cultures. In competition experiments, when 125I-TGF-β1 was used as the radiotracer, the Type I and II TGF-β receptors show a much higher affinity for TGF-β1 than for TGF-β2, as observed with other cell types. However, when 125I-TGF-β2 was used, low abundance subtypes of both the Type I and II receptors that show similar affinities for TGF-β1 and TGF-β2 were also revealed.Keywords
This publication has 44 references indexed in Scilit:
- Transforming growth factor-β suppresses the invasiveness of human fibrosarcoma cells in vitro by increasing expression of tissue inhibitor of metalloproteaseBiochemical and Biophysical Research Communications, 1991
- The Transforming Growth Factor-beta FamilyAnnual Review of Cell Biology, 1990
- A Class I Antigen, HLA-G, Expressed in Human TrophoblastsScience, 1990
- Antibodies to Transforming Growth Factor-β2 Peptides: Specific Detection of TGF-β2 in ImmunoassaysGrowth Factors, 1990
- Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta.The Journal of cell biology, 1989
- Growth factors, protooncogenes and human placental developmentCell Differentiation and Development, 1989
- Two forms of transforming growth factor-β distinguished by multipotential haematopoietic progenitor cellsNature, 1987
- Antigen expression by trophoblast populations in the human placenta and their possible immunobiological relevancePlacenta, 1985
- Receptors, acceptors, and the action of polypeptide hormones: illustrative studies with epidermal growth factor (urogastrone)Canadian Journal of Biochemistry and Cell Biology, 1983
- Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysisCell, 1978